Betulinic Acid has been used in trials studying the treatment of Dysplastic Nevus Syndrome.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Diclofenac | The risk or severity of adverse effects can be increased when Diclofenac is combined with Betulinic Acid. |
| Flurbiprofen | The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Betulinic Acid. |
| Bromfenac | The risk or severity of adverse effects can be increased when Bromfenac is combined with Betulinic Acid. |
| Nepafenac | The risk or severity of adverse effects can be increased when Nepafenac is combined with Betulinic Acid. |
| Indomethacin | The risk or severity of adverse effects can be increased when Indomethacin is combined with Betulinic Acid. |
| Nabumetone | The risk or severity of adverse effects can be increased when Nabumetone is combined with Betulinic Acid. |
| Tenoxicam | The risk or severity of adverse effects can be increased when Tenoxicam is combined with Betulinic Acid. |
| Celecoxib | The risk or severity of adverse effects can be increased when Celecoxib is combined with Betulinic Acid. |
| Tolmetin | The risk or severity of adverse effects can be increased when Tolmetin is combined with Betulinic Acid. |
| Rofecoxib | The risk or severity of adverse effects can be increased when Rofecoxib is combined with Betulinic Acid. |
| Piroxicam | The risk or severity of adverse effects can be increased when Piroxicam is combined with Betulinic Acid. |
| Fenoprofen | The risk or severity of adverse effects can be increased when Fenoprofen is combined with Betulinic Acid. |
| Valdecoxib | The risk or severity of adverse effects can be increased when Valdecoxib is combined with Betulinic Acid. |
| Sulindac | The risk or severity of adverse effects can be increased when Sulindac is combined with Betulinic Acid. |
| Etodolac | The risk or severity of adverse effects can be increased when Etodolac is combined with Betulinic Acid. |
| Mefenamic acid | The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Betulinic Acid. |
| Naproxen | The risk or severity of adverse effects can be increased when Naproxen is combined with Betulinic Acid. |
| Sulfasalazine | The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Betulinic Acid. |
| Phenylbutazone | The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Betulinic Acid. |
| Meloxicam | The risk or severity of adverse effects can be increased when Meloxicam is combined with Betulinic Acid. |
| Carprofen | The risk or severity of adverse effects can be increased when Carprofen is combined with Betulinic Acid. |
| Diflunisal | The risk or severity of adverse effects can be increased when Diflunisal is combined with Betulinic Acid. |
| Suprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Betulinic Acid. |
| Salicylic acid | The risk or severity of adverse effects can be increased when Salicylic acid is combined with Betulinic Acid. |
| Meclofenamic acid | The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Betulinic Acid. |
| Oxaprozin | The risk or severity of adverse effects can be increased when Oxaprozin is combined with Betulinic Acid. |
| Ketoprofen | The risk or severity of adverse effects can be increased when Ketoprofen is combined with Betulinic Acid. |
| Balsalazide | The risk or severity of adverse effects can be increased when Balsalazide is combined with Betulinic Acid. |
| Ibuprofen | The risk or severity of adverse effects can be increased when Ibuprofen is combined with Betulinic Acid. |
| Lumiracoxib | The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Betulinic Acid. |
| Magnesium salicylate | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Betulinic Acid. |
| Salsalate | The risk or severity of adverse effects can be increased when Salsalate is combined with Betulinic Acid. |
| Choline magnesium trisalicylate | The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Betulinic Acid. |
| Antipyrine | The risk or severity of adverse effects can be increased when Antipyrine is combined with Betulinic Acid. |
| Tiaprofenic acid | The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Betulinic Acid. |
| Etoricoxib | The risk or severity of adverse effects can be increased when Etoricoxib is combined with Betulinic Acid. |
| Oxyphenbutazone | The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Betulinic Acid. |
| Niflumic acid | The risk or severity of adverse effects can be increased when Niflumic acid is combined with Betulinic Acid. |
| Benoxaprofen | The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Betulinic Acid. |
| Zomepirac | The risk or severity of adverse effects can be increased when Zomepirac is combined with Betulinic Acid. |
| Lornoxicam | The risk or severity of adverse effects can be increased when Lornoxicam is combined with Betulinic Acid. |
| Aceclofenac | The risk or severity of adverse effects can be increased when Aceclofenac is combined with Betulinic Acid. |
| Zaltoprofen | The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Betulinic Acid. |
| Azapropazone | The risk or severity of adverse effects can be increased when Azapropazone is combined with Betulinic Acid. |
| Felbinac | The risk or severity of adverse effects can be increased when Felbinac is combined with Betulinic Acid. |
| Parecoxib | The risk or severity of adverse effects can be increased when Parecoxib is combined with Betulinic Acid. |
| Salicylamide | The risk or severity of adverse effects can be increased when Salicylamide is combined with Betulinic Acid. |
| Kebuzone | The risk or severity of adverse effects can be increased when Kebuzone is combined with Betulinic Acid. |
| Isoxicam | The risk or severity of adverse effects can be increased when Isoxicam is combined with Betulinic Acid. |
| Indoprofen | The risk or severity of adverse effects can be increased when Indoprofen is combined with Betulinic Acid. |
| Ibuproxam | The risk or severity of adverse effects can be increased when Ibuproxam is combined with Betulinic Acid. |
| Floctafenine | The risk or severity of adverse effects can be increased when Floctafenine is combined with Betulinic Acid. |
| Fenbufen | The risk or severity of adverse effects can be increased when Fenbufen is combined with Betulinic Acid. |
| Etofenamate | The risk or severity of adverse effects can be increased when Etofenamate is combined with Betulinic Acid. |
| Epirizole | The risk or severity of adverse effects can be increased when Epirizole is combined with Betulinic Acid. |
| Loxoprofen | The risk or severity of adverse effects can be increased when Loxoprofen is combined with Betulinic Acid. |
| Droxicam | The risk or severity of adverse effects can be increased when Droxicam is combined with Betulinic Acid. |
| Tolfenamic acid | The risk or severity of adverse effects can be increased when Tolfenamic acid is combined with Betulinic Acid. |
| Clonixin | The risk or severity of adverse effects can be increased when Clonixin is combined with Betulinic Acid. |
| Tepoxalin | The risk or severity of adverse effects can be increased when Tepoxalin is combined with Betulinic Acid. |
| Flunixin | The risk or severity of adverse effects can be increased when Flunixin is combined with Betulinic Acid. |
| Tinoridine | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Tinoridine. |
| Alclofenac | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Alclofenac. |
| Fentiazac | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Fentiazac. |
| Suxibuzone | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Suxibuzone. |
| Bumadizone | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Bumadizone. |
| Alminoprofen | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Alminoprofen. |
| Bufexamac | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Bufexamac. |
| Feprazone | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Feprazone. |
| Difenpiramide | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Difenpiramide. |
| Nifenazone | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Nifenazone. |
| Lonazolac | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Lonazolac. |
| Tenidap | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Tenidap. |
| Bendazac | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Bendazac. |
| Pranoprofen | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Pranoprofen. |
| Propyphenazone | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Propyphenazone. |
| Proglumetacin | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Proglumetacin. |
| Guacetisal | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Guacetisal. |
| Ethenzamide | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Ethenzamide. |
| Carbaspirin calcium | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Carbaspirin calcium. |
| Mofebutazone | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Mofebutazone. |
| Proquazone | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Proquazone. |
| Benorilate | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Benorilate. |
| Pirprofen | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Pirprofen. |
| Acemetacin | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Acemetacin. |
| Imidazole salicylate | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Imidazole salicylate. |
| Benzydamine | The risk or severity of adverse effects can be increased when Benzydamine is combined with Betulinic Acid. |
| Icosapent | The risk or severity of adverse effects can be increased when Icosapent is combined with Betulinic Acid. |
| Antrafenine | The risk or severity of adverse effects can be increased when Antrafenine is combined with Betulinic Acid. |
| Dexibuprofen | The risk or severity of adverse effects can be increased when Dexibuprofen is combined with Betulinic Acid. |
| Trolamine salicylate | The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Betulinic Acid. |
| Cimicoxib | The risk or severity of adverse effects can be increased when Cimicoxib is combined with Betulinic Acid. |
| Robenacoxib | The risk or severity of adverse effects can be increased when Robenacoxib is combined with Betulinic Acid. |
| Aminophenazone | The risk or severity of adverse effects can be increased when Aminophenazone is combined with Betulinic Acid. |
| Mesalazine | The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Betulinic Acid. |
| SC-236 | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with SC-236. |
| NS-398 | The risk or severity of adverse effects can be increased when Betulinic Acid is combined with NS-398. |
| Firocoxib | The risk or severity of adverse effects can be increased when Firocoxib is combined with Betulinic Acid. |
| Morniflumate | The risk or severity of adverse effects can be increased when Morniflumate is combined with Betulinic Acid. |
| Talniflumate | The risk or severity of adverse effects can be increased when Talniflumate is combined with Betulinic Acid. |